Search Result "PHD3"
PHD3 as a Prognosis Marker and its Relationship with Immune Infiltrationin Lung Adenocarcinoma
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 25 Issue: 13 Year: 2022 Page: 2255-2263
Author(s):
Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 9 Year: 2014 Page: 1305-1310
Author(s): Babatunde Oriowo,Mahesh Thirunavukkarasu,Vaithinathan Selvaraju,Ram Sudheer Adluri,Lijun Zhan,Kotaro Takeda,Guo-Hua Fong,Juan A. Sanchez,Nilanjana Maulik
Siah2 Inhibitor and the Metabolic Antagonist Oxamate Retard ColonCancer Progression and Downregulate PD1 Expression
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 1 Year: 2024 Page: 80-92
Author(s):
Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 1 Issue: 2 Year: 2006 Page: 129-139
Author(s): Nangaku Nangaku, Ichiro Kojima, Tetsuhiro Tanaka, Takamoto Ohse, Hideki Kato, Fujita Fujita
HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 3886-3894
Author(s): Roland H. Wenger, Gieri Camenisch, Daniel P. Stiehl, Dorthe M. Katschinski
Effects of Oxygen Depletion on Transmembrane Protein Activities
Journal: Current Organic Chemistry
Volume: 19 Issue: 20 Year: 2015 Page: 2002-2010
Author(s): Nadezhda N. Barvitenko,Muhammad Aslam,Alfons Lawen,Antonella Pantaleo,Carlota Saldanha,Elena Matteucci
Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 4 Year: 2013 Page: 578-613
Author(s): Federico Andreoli, Armenio Jorge Moura Barbosa, Marco Daniele Parenti, Alberto Del Rio
Modulation of Erythropoietin Gene Expression
Ebook: Frontiers in Drug Discovery
Volume: 1 Year: 2013
Author(s): João C. Fernandes,Flávio Reis,ElÃsio Costa,Alice Santos-Silva
Doi: 10.2174/9781608057474113010005
HIF Prolyl 4-Hydroxylases and their Potential as Drug Targets
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 3 Year: 2009 Page: 3878-3885
Author(s): Johanna Myllyharju
HIF Inhibitors: New Hope for Cancer Therapy
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 9 Year: 2015 Page: 736-753
Author(s): Mayur Poddar,Tejraj M. Aminabhavi,Meghna Patel,Navdeep Singh,Malleshappa N. Noolvi